Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). 1992

U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
Department of Haematology, University of Frankfurt, Germany.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016178 Granulocyte-Macrophage Colony-Stimulating Factor An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. CSF-GM,Colony-Stimulating Factor, Granulocyte-Macrophage,GM-CSF,Histamine-Producing Cell-Stimulating Factor,CSF-2,TC-GM-CSF,Tumor-Cell Human GM Colony-Stimulating Factor,Cell-Stimulating Factor, Histamine-Producing,Colony Stimulating Factor, Granulocyte Macrophage,Granulocyte Macrophage Colony Stimulating Factor,Histamine Producing Cell Stimulating Factor,Tumor Cell Human GM Colony Stimulating Factor
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
January 1991, Cellular and molecular biology,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
August 1988, Behring Institute Mitteilungen,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
April 1989, Biochemical and biophysical research communications,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
September 1992, British journal of haematology,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
January 1993, Haematologica,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
June 1995, The American journal of medicine,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
November 1994, Blood,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
January 1990, Haematologica,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
February 1993, Leukemia research,
U Hess, and A Ganser, and H G Schnürch, and G Seipelt, and O G Ottmann, and S Falk, and G Schulz, and D Hoelzer
January 1991, Bone marrow transplantation,
Copied contents to your clipboard!